Orange Book product · Brand (NDA)
REQUIP XL
ROPINIROLE HYDROCHLORIDE
At a glance
Jun 13, 2008
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 13, 2008
18 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
ROPINIROLE HYDROCHLORIDE
Strength
EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 022008
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 1997REQUIPBrand (NDA)
NDA 020658 · GLAXOSMITHKLINE LLC
- 2025ROPINIROLE HYDROCHLORIDEGeneric (ANDA)
ANDA 217862 · ELITE LABS INC
- 2022ROPINIROLE HYDROCHLORIDEGeneric (ANDA)
ANDA 204413 · PRINSTON INC
- 2017ROPINIROLE HYDROCHLORIDEGeneric (ANDA)
ANDA 204022 · ACCORD HLTHCARE
- 2013ROPINIROLE HYDROCHLORIDEGeneric (ANDA)
ANDA 202786 · ALEMBIC
- 2012ROPINIROLE HYDROCHLORIDEGeneric (ANDA)
ANDA 079229 · ORBION PHARMS
- 2012ROPINIROLE HYDROCHLORIDEGeneric (ANDA)
ANDA 200462 · AUROBINDO PHARMA USA
- 2012ROPINIROLE HYDROCHLORIDEGeneric (ANDA)
ANDA 091395 · CHARTWELL RX
- 2012ROPINIROLE HYDROCHLORIDEGeneric (ANDA)
ANDA 201576 · DR REDDYS LABS LTD
- 2012ROPINIROLE HYDROCHLORIDEGeneric (ANDA)
ANDA 201047 · SANDOZ INC
- 2012ROPINIROLE HYDROCHLORIDEGeneric (ANDA)
ANDA 200431 · WATSON LABS INC
- 2012ROPINIROLE HYDROCHLORIDEGeneric (ANDA)
ANDA 090869 · ACTAVIS ELIZABETH
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

